Henan University People’s Hospital Reports Findings in Liver Cancer (Machine lea rning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a ...)

扫码查看

原文链接

NETL
NSTL

外文摘要：By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Oncology - Liver Cance r is the subject of a report. According tonews reporting from Zhengzhou, People ’s Republic of China, by NewsRx journalists, research stated, “Theobjective of this study is to build and verify the performance of machine learning-based ultr asomics inpredicting the objective response to combination therapy involving a tyrosine kinase inhibitor (TKI) andanti-PD-1 antibody for individuals with unre sectable hepatocellular carcinoma (HCC). Radiomic featurescan reflect the inter nal heterogeneity of the tumor and changes in its microenvironment.”

外文关键词：

ZhengzhouPeople’s Republic of ChinaA siaAmino AcidsAntibodiesAromatic Amino AcidsBlood ProteinsCancerCarc inomasCyborgsDrugs and TherapiesEmerging TechnologiesEnzyme InhibitorsEnzymes and CoenzymesHealth and MedicineHospitalsImmunoglobulinsImmunolo gyImmunotherapyKinaseLiver CancerMachine LearningOncologyProteinsP roteomicsTyrosineTyrosine KinaseTyrosine Kinase Inhibitors

出版年：

2024

Robotics & Machine Learning Daily News

ISSN：

年,卷(期)：2024.(Dec.9)